Perioperative and Palliative Chemotherapy for Esophageal Cancer

Perioperative and palliative chemotherapy for esophageal carcinoma has undergone substantial changes in recent years. The implementation of trastuzumab in the treatment of HER2-positive advanced adenocarcinoma is a milestone as it marked the introduction of the first molecularly targeted treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrens, Angelika, Ell, Christian, Lordick, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger Verlag für Medizin und Naturwissenschaften GmbH 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789901/
https://www.ncbi.nlm.nih.gov/pubmed/26989390
http://dx.doi.org/10.1159/000438470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789901/
https://www.ncbi.nlm.nih.gov/pubmed/26989390
http://dx.doi.org/10.1159/000438470

Ejemplares similares